UK Health Security Agency (UKHSA) has released its latest flu and COVID-19 surveillance reports for 2025, providing updates on the current status of these viruses in England.
Surveillance Overview
The UKHSA’s surveillance reports are crucial for monitoring influenza and COVID-19 activity across England. These reports integrate data from various surveillance systems, including laboratory-confirmed cases, primary and secondary care surveillance, and respiratory virus monitoring.
As of week 5 in 2025, influenza activity has decreased across most indicators, maintaining medium levels, while COVID-19 activity remains stable at baseline levels. There is a noted increase in influenza B activity in some areas.
The reports highlight the importance of continued vigilance and public health measures to manage these viruses. The data also show a decrease in flu positivity and hospitalizations, indicating a slight easing of pressure on healthcare services.
Additionally, the reports emphasize the role of vaccination in controlling flu outbreaks, with specific uptake rates reported for different age groups and risk categories.
Flu and COVID-19 Trends
In week 5, flu positivity decreased to a weekly mean of 14%, down from 15.6% in the previous week. This trend reflects a reduction in flu-related hospitalizations to 6.40 per 100,000 population, compared to 7.00 per 100,000 previously. COVID-19 activity, however, has remained stable, with no significant changes in case rates or hospital admissions.
The stability in COVID-19 activity is consistent with baseline levels, indicating that the virus is no longer causing significant disruptions to public health. Meanwhile, the decrease in flu activity suggests that public health measures and vaccination efforts are having a positive effect.
Respiratory syncytial virus (RSV) activity has also decreased, contributing to an overall reduction in respiratory virus circulation.
| Indicator | Week 5 Data | Previous Week Data |
|---|---|---|
| Flu Positivity Rate | 14% | 15.6% |
| Flu Hospitalizations per 100,000 | 6.40 | 7.00 |
| COVID-19 Activity Level | Stable at Baseline | Stable at Baseline |
Vaccination Efforts
Vaccination remains a critical component of managing flu and COVID-19. As of the end of week 4, flu vaccine uptake was reported at 39.7% for those under 65 in clinical risk groups, 34.8% for pregnant women, and 74.6% for those aged 65 and over. For children, uptake was 41.4% for those aged 2 and 43.2% for those aged 3.
These figures highlight the ongoing efforts to protect vulnerable populations through vaccination. Public health campaigns continue to emphasize the importance of vaccination in preventing severe illness and reducing the spread of these viruses.
The reports also underscore the need for continued monitoring and adaptation of vaccination strategies to address evolving virus strains and population needs.
Related Policies
- Living with COVID-19 Plan: This plan outlines the UK’s approach to managing COVID-19, including changes in testing policies and public health guidance.
- Flu Vaccination Program: An annual program aimed at increasing flu vaccine uptake among high-risk groups to reduce hospitalizations and severe outcomes.
Did You Know?
The UKHSA’s surveillance reports are based on data from multiple sources, including laboratory tests and primary care consultations, providing a comprehensive view of respiratory virus activity in England.
As of week 5, the weekly influenza-like illnesses (ILI) consultation rate decreased to 13.9 per 100,000, reflecting a reduction in flu activity.
Future Implications
The trends observed in flu and COVID-19 activity have significant implications for future public health strategies. As these viruses continue to evolve, ongoing surveillance and adaptation of vaccination programs will be crucial to maintaining control. The stability in COVID-19 activity suggests that current measures are effective, but vigilance is necessary to address potential future waves.
The decrease in flu activity may indicate a shift towards more seasonal patterns, but continued monitoring is essential to respond to any resurgence. Public health messaging and vaccination efforts will remain critical components of managing these viruses in the long term.
Additionally, the impact of changes in testing policies on case reporting rates must be considered when interpreting surveillance data.
Closing Thoughts
The latest surveillance reports from the UKHSA provide valuable insights into the current state of flu and COVID-19 in England. These updates underscore the importance of continued public health efforts, including vaccination and surveillance, to manage these viruses effectively.
As the situation evolves, it is crucial for the public to remain informed and adhere to public health advice to mitigate the effect of these viruses.
For those interested in staying updated on the latest developments, the UKHSA’s weekly reports offer comprehensive data and insights into respiratory virus activity in England. F
Further information can be found on the UKHSA website and through local health services.
